0010 Using Chronotype and Polygenic Risk Scores to Predict Age of Mood Symptom Onset in People with Bipolar Disorder

Alannah Miranda,Breanna Holloway,William Perry,Arpi Minassian,Michael McCarthy
DOI: https://doi.org/10.1093/sleep/zsae067.0010
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction Sleep and circadian rhythm disturbances are hallmark features of people with bipolar disorder (BD). Genetic and preclinical models of BD suggest that disruption of the circadian clock may predispose individuals with BD towards disruption of sleep/wake cycles. Phase delays in sleep/wake cycles are common in BD, causing difficulty initiating morning behaviors. Many people with BD report regularly using cannabis to ameliorate sleep disturbances. Although cannabis has been shown to have sedative properties, cannabis use may also destabilize mood and worsen sleep, and circadian disruption may also increase the risk of problematic substance use. Therefore, it remains unclear how cannabis use impacts sleep and circadian rhythms in people with BD. Here, we determined whether chronotype (self-reported and polygenic scores) and cannabis use disorder (CUD) predicted BD mood symptom onset. Methods Participants with BD I (n=309) from the Pharmacogenomics of Bipolar Disorder study were studies. The Diagnostic Interview for Genetic Studies was used to confirm BD and CUD diagnoses. Polygenic scores (PGS) were calculated for chronotype and BD. Basic Language Morningness scale (BALM) was used to assess chronotype. Bivariate correlation analyses were performed between morningness, PGS, and BD symptoms. Multiple regression analyses were performed using gender, morningness, or PGS, and CUD as predictors, and BD symptoms as the dependent variables. Results Morningness was not significantly correlated with PGS for chronotype. Higher morningness was positively correlated with onset of manic symptoms (p< 0.001) and mean number of mood episodes per year. Both CUD and BALM scores significantly predicted BD age of onset (p< 0.05); greater morningness delayed age of onset and patients with CUD had an earlier age of onset. Conclusion Consistent with a role in destabilizing mood, CUD use is associated with earlier age of onset, while morningness appears protective, and associated with later age of onset. The study is limited by its cross-sectional and retrospective design. Future studies should continue to explore the interaction of CUD and chronotype in BD patients using cannabis for sleep. Support (if any) NIDA R01DA043535 and R01DA051295
neurosciences,clinical neurology
What problem does this paper attempt to address?